<!DOCTYPE html>
<html lang="en" class=" >
  <head>
    <title></title>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width" />
    <meta name="theme-color" content="#D45D00">

    <link rel="stylesheet" href="../../css/main.css?1729607112045" media="all" />
    <link rel="stylesheet" href="../../css/pattern-scaffolding.css?1729607112045" media="all" />
    
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Lora:ital@0;1&family=Nunito+Sans:wght@200;300;400;600;700;800;900&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/charts.css/dist/charts.min.css">

    <!-- Begin Pattern Lab (Required for Pattern Lab to run properly) -->
    
    <!-- End Pattern Lab -->
  </head>
  <body class=""><div class="off-canvas position-right" id="offCanvasRight" data-off-canvas>
    <!-- Quicklinks Content -->
    <div class="title-bar quicklinks">
        <div class="title-bar-left">
            <p><a href="#" data-close="offCanvasRight"><i class="fas fa-times"></i> Quicklinks</a></p>
            <form class="search">
    <input type="search" class="search-box" placeholder="Search">
    <button type="submit">
        <i class="fa fa-search"></i>
    </button>
</form>            <h4>Find</h4>
            <div class="no-bullet arrow">
                <ul>
                    <li><a href="#">A to Z list</a></li>
                    <li><a href="#">Alumni</a></li>
                    <li><a href="#">Calendars</a></li>
                    <li><a href="#">Directories</a></li>
                </ul>
            </div>
            <h4>Media</h4>
            <div class="no-bullet arrow">
                <ul>
                    <li><a href="#">COVID-19</a></li>
                    <li><a href="#">IMPACT COVID Magazine</a></li>
                    <li><a href="#">MissionRX</a></li>
                    <li><a href="#">Newsroom</a></li>
                    <li><a href="#">ENGAGED</a></li>
                </ul>
            </div>
            <h4>Logins</h4>
            <div class="no-bullet arrow">
                <ul>
                    <li><a href="#">Canvas</a></li>
                    <li><a href="#">Employee Email</a></li>
                    <li><a href="#">MyUTHealth</a></li>
                    <li><a href="#">LiveMail</a></li>
                    <li><a href="#">My Student Center</a></li>
                    <li><a href="#">UT Health Learns</a></li>
                </ul>
            </div>
            <h4>Technology</h4>
            <div class="no-bullet arrow">
                <ul>
                    <li><a href="#">Service Desk</a></li>
                    <li><a href="#">Password Reset</a></li>
                    <li><a href="#">TechZone (Computer Store)</a></li>
                </ul>
            </div>
            <h4>More</h4>
            <div class="no-bullet arrow">
                <ul>
                    <li><a href="#">Library</a></li>
                    <li><a href="#">Bookstore</a></li>
                    <li><a href="#">Course Catalog</a></li>
                    <li><a href="#">Human Resources</a></li>
                </ul>
            </div>
        </div>
    </div>
</div>
<header class="title-bar" data-responsive-toggle="header">
    <a href="#"><img src="../../images/whiteUTHSA_logo.svg"></a>
    <button class="menu-icon" type="button" data-toggle="header">Menu</button>
</header>
<header class="off-canvas-content" id="header" data-off-canvas-content>
    <div class="group">
        <div class="logo pipe">
            <a href="#"><img src="../../images/UTHSA_logo.svg" alt="UT Health San Antonio"></a>
            <p>San Antonio Claude D. Pepper Center</p>
        </div>

        <div class="right">
            <div class="circle-icons">
                <a href="#">
                    <span class="fa-stack outline">
                        <i class="far fa-circle fa-stack-2x"></i>
                        <i class="fas fa-landmark fa-stack-1x fa-inverse"></i>
                    </span>
                    <span>Barshop Institute</span>
                </a>
                <a href="#" data-toggle="offCanvasRight">
                    <span class="fa-stack outline">
                        <i class="fas fa-circle fa-stack-2x"></i>
                        <i class="fas fa-search fa-stack-1x fa-inverse"></i>
                    </span>
                    <span>Search/Quicklinks</span>
                </a>
            </div>
        </div>
    </div>
    <nav class="nav-bar" id="nav-bar-mobile">
        <div class="top-bar">
            <div class="top-bar-left">
                <ul class="menu">
                    <li><a href="#">Home</a></li>
                    <li><a href="#">About</a></li>
                    <li><a href="#">Cores</a></li>
                    <li><a href="#">News</a></li>
                    <li><a href="#">Publications</a></li>
                </ul>
            </div>
        </div>
    </nav>
</header><nav class="nav-bar" id="nav-bar-full">
    <div class="top-bar">
        <div class="top-bar-left">
            <ul class="menu">
                    <li><a href="#">Home</a></li>
                    <li><a href="#">About</a></li>
                    <li><a href="#">Cores</a></li>
                    <li><a href="#">News</a></li>
                    <li><a href="#">Publications</a></li>
            </ul>
        </div>
    </div>
</nav><section class="grid-container">
    <div class="grid-x grid-margin-x">
        <main class="cell small-12 medium-7 large-8 small-order-2 medium-order-1">
            <p id="start">
            <h1>Publications</h1>
            <h2 class="h4"><a href="#">TREX2 Exonuclease Causes Spontaneous Mutations and Stress-Induced Replication Fork Defects in Cells Expressing RAD51K133A</a>
            </h2>
            <p> Jun Ho Ko, Mi Young Son, Qing Zhou, Lucia Molnarova, Lambert Song, Jarmila Mlcouskova, Atis Jekabsons, Cristina Montagna, Lumir Krejci, Paul Hasty</p>
            <p><i>Cell Reports</i>. Volume 33, Issue 12, 22 December 2020, 108543. doi: 10.1016/j.celrep.2020.108543.</p>
            <p><strong>Summary:</strong></p>
            <p>DNA damage tolerance (DDT) and homologous recombination (HR) stabilize replication forks (RFs). RAD18/UBC13/three prime repair exonuclease 2 (TREX2)-mediated proliferating cell nuclear antigen (PCNA) ubiquitination is central to DDT, an error-prone lesion bypass pathway. RAD51 is the recombinase for HR. The RAD51 K133A mutation increased spontaneous mutations and stress-induced RF stalls and nascent strand degradation. Here, we report in RAD51K133A cells that this phenotype is reduced by expressing a TREX2 H188A mutation that deletes its exonuclease activity. In RAD51K133A cells, knocking out RAD18 or overexpressing PCNA reduces spontaneous mutations, while expressing ubiquitination-incompetent PCNAK164R increases mutations, indicating DDT as causal. Deleting TREX2 in cells deficient for the RF maintenance proteins poly(ADP-ribose) polymerase 1 (PARP1) or FANCB increased nascent strand degradation that was rescued by TREX2H188A, implying that TREX2 prohibits degradation independent of catalytic activity. A possible explanation for this occurrence is that TREX2H188A associates with UBC13 and ubiquitinates PCNA, suggesting a dual role for TREX2 in RF maintenance.</p>
            <hr>

            <h2 class="h4"><a href="#">Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes.</a></h2>
            <p>Juan P Palavicini, Juan Chen, Chunyan Wang, Jianing Wang, Chao Qin, Eric Baeuerle, Xinming Wang, Jung A Woo, David E Kang, Nicolas Musi, Jeffrey L Dupree, Xianlin Han.</p>
            <p><i>JCI Insight</i>. 2020 Nov 5;5(21):137286. doi: 10.1172/jci.insight.137286.</p>
            <p><strong>Abstract:</strong></p>
            <p>Diabetic neuropathy is a major complication of diabetes. Current treatment options alleviate pain but do not stop the progression of the disease. At present, there are no approved disease-modifying therapies. Thus, developing more effective therapies remains a major unmet medical need. Seeking to better understand the molecular mechanisms driving peripheral neuropathy, as well as other neurological complications associated with diabetes, we performed spatiotemporal lipidomics, biochemical, ultrastructural, and physiological studies on PNS and CNS tissue from multiple diabetic preclinical models. We unraveled potentially novel molecular fingerprints underlying nerve damage in obesity-induced diabetes, including an early loss of nerve mitochondrial (cardiolipin) and myelin signature (galactosylceramide, sulfatide, and plasmalogen phosphatidylethanolamine) lipids that preceded mitochondrial, myelin, and axonal structural/functional defects; started in the PNS; and progressed to the CNS at advanced diabetic stages. Mechanistically, we provided substantial evidence indicating that these nerve mitochondrial/myelin lipid abnormalities are (surprisingly) not driven by hyperglycemia, dysinsulinemia, or insulin resistance, but rather associate with obesity/hyperlipidemia. Importantly, our findings have major clinical implications as they open the door to novel lipid-based biomarkers to diagnose and distinguish different subtypes of diabetic neuropathy (obese vs. nonobese diabetics), as well as to lipid-lowering therapeutic strategies for treatment of obesity/diabetes-associated neurological complications and for glycemic control.</p>
            <hr>

            <h2 class="h4"><a href="#">Pathogenic Tau Causes a Toxic Depletion of Nuclear Calcium.</a></h2>
            <p>Rebekah Mahoney, Elizabeth Ochoa Thomas, Paulino Ramirez, Henry E Miller, Adrian Beckmann, Gabrielle Zuniga, Radek Dobrowolski, Bess Frost.</p>
            <p><i>Cell Reports</i>. 2020 Jul 14;32(2):107900. doi: 10.1016/j.celrep.2020.107900.</p>
            <p><strong>Abstract:</strong></p>
            <p>Synaptic activity-induced calcium (Ca2+) influx and subsequent propagation into the nucleus is a major way in which synapses communicate with the nucleus to regulate transcriptional programs important for activity-dependent survival and memory formation. Nuclear Ca2+ shapes the transcriptome by regulating cyclic AMP (cAMP) response element-binding protein (CREB). Here, we utilize a Drosophila model of tauopathy and induced pluripotent stem cell (iPSC)-derived neurons from humans with Alzheimer’s disease to study the effects of pathogenic tau, a pathological hallmark of Alzheimer’s disease and related tauopathies, on nuclear Ca2+. We find that pathogenic tau depletes nuclear Ca2+ and CREB to drive neuronal death, that CREB-regulated genes are over-represented among differentially expressed genes in tau transgenic Drosophila, and that activation of big potassium (BK) channels elevates nuclear Ca2+ and suppresses tau-induced neurotoxicity. Our studies identify nuclear Ca2+ depletion as a mechanism contributing to tau-induced neurotoxicity, adding an important dimension to the calcium hypothesis of Alzheimer’s disease.</p>
            <hr>

            <h2 class="h4"><a href="#">Awakening the dark side: retrotransposon activation in neurodegenerative disorders.</a></h2>
            <p>Elizabeth Ochoa Thomas, Gabbe Zuniga, Wenyan Sun, Bess Frost.</p>
            <p><i>Current Opinion in Neurobiology</i>. 2020 Apr;61:65-72. doi: 10.1016/j.conb.2020.01.012. Epub 2020 Feb 21.</p>
            <p><strong>Abstract:</strong></p>
            <p>Nearly half (45%) of the human genome is composed of transposable elements, or ‘jumping genes’. Since Barbara McClintock’s original discovery of transposable elements in 1950, we have come to appreciate that transposable element mobilization is a major driver of evolution that transposons are active in the germline and the soma, and that transposable element dysregulation is causally associated with many human disorders. In the present review, we highlight recent studies investigating transposable element activation in the adult brain and in the context of neurodegeneration. Collectively, these studies contribute to a greater understanding of the frequency of complete retrotransposition in the adult brain as well as the presence of transposable element-derived RNA and protein in brain and fluids of patients with neurodegenerative disorders. We discuss therapeutic opportunities and speculate on the larger implications of transposable element activation in regard to current hot topics in the field of neurodegeneration.</p>
            <hr>

            <h2 class="h4"><a href="#">mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging.</a></h2>
            <p> Van Skike CE, Lin AL, Roberts Burbank R, Halloran JJ, Hernandez SF, Cuvillier J, Soto VY, Hussong SA, Jahrling JB, Javors MA, Hart MJ, Fischer KE, Austad SN, Galvan V.</p>
            <p><i>Aging Cell</i>. 2020 Jan;19(1):e13057. doi: 10.1111/acel.13057. Epub 2019 Nov 6.</p>
            <p><strong>Abstract:</strong></p>
            <p>Cerebrovascular dysfunction and cognitive decline are highly prevalent in aging, but the mechanisms underlying these impairments are unclear. Cerebral blood flow decreases with aging and is one of the earliest events in the pathogenesis of Alzheimer’s disease (AD). We have previously shown that the mechanistic/mammalian target of rapamycin (mTOR) drives disease progression in mouse models of AD and in models of cognitive impairment associated with atherosclerosis, closely recapitulating vascular cognitive impairment. In the present studies, we sought to determine whether mTOR plays a role in cerebrovascular dysfunction and cognitive decline during normative aging in rats. Using behavioral tools and MRI-based functional imaging, together with biochemical and immunohistochemical approaches, we demonstrate that chronic mTOR attenuation with rapamycin ameliorates deficits in learning and memory, prevents neurovascular uncoupling, and restores cerebral perfusion in aged rats. Additionally, morphometric and biochemical analyses of hippocampus and cortex revealed that mTOR drives age-related declines in synaptic and vascular density during aging. These data indicate that in addition to mediating AD-like cognitive and cerebrovascular deficits in models of AD and atherosclerosis, mTOR drives cerebrovascular, neuronal, and cognitive deficits associated with normative aging. Thus, inhibitors of mTOR may have potential to treat age-related cerebrovascular dysfunction and cognitive decline. Since treatment of age-related cerebrovascular dysfunction in older adults is expected to prevent further deterioration of cerebral perfusion, recently identified as a biomarker for the very early (preclinical) stages of AD, mTOR attenuation may potentially block the initiation and progression of AD.</p>
            <hr>

            <h2 class="h4"><a href="#">Age-dependent autophagy induction after injury promotes axon regeneration by limiting NOTCH.</a></h2>
            <p>Ko SH, Apple EC, Liu Z, Chen L</p>
            <p><i>Autophagy</i>. 2020 Jan 13:1-17. doi: 10.1080/15548627.2020.1713645. [Epub ahead of print]</p>
            <p><strong>Abstract:</strong></p>
            <p>Macroautophagy/autophagy is essential for maintaining cellular homeostasis through the degradation of organelles and proteins. It also has a prominent role in modulating aging. However, the role of autophagy in the neuronal response to axon injury and axon regeneration, particularly in the context of aging, remains largely unknown. Our candidate genetic screen for axon regeneration regulators has identified genes in the autophagy pathway. Using a reporter that monitors autophagosomes and autolysosomes, we were able to monitor the dynamics of autophagy during axon regeneration. In response to axon injury, there was a significant increase in the number of autophagic vesicles. Injury-triggered autophagy activation and axon regeneration capacity undergo an age-dependent decline, and autophagy-activating agents partially rescued these declines. We found that DLK-1 was both required and sufficient for injury-induced autophagy activation. Autophagic vesicles co-localized with the NOTCH4 ortholog, LIN-12 receptor, a previously identified inhibitor of axon regeneration. Epistasis analyses indicate that LIN-12 might be a target of autophagy in axon regeneration. Together, our data suggest that DLK-mediated injury signaling can activate autophagy, which might limit the level of LIN-12 and NOTCH proteins to promote axon regeneration. Our findings reveal that autophagy activation can promote axon regeneration in neurons that lack maximal regrowth capacity, providing a promising therapeutic strategy for axon injury.</p>
            <p><strong>Abbreviations:</strong> 3-MA: 3-methyladenine; ALs: autolysosomes; APs: autophagosomes; ARF-6: ADP-Ribosylation Factor related 6; ATG-9: AuTophaGy (yeast Atg homolog) 9; ATG9A: autophagy related 9A; BA1: bafilomycin A1; BEC-1: BEClin (human autophagy) homolog; BECN1: beclin 1; C. elegans: Caenorhabditis elegans; CEBP-1: C/EBP (CCAAT/enhancer-binding protein) homolog; CNS: central nervous system; DLK-1: Dual-Leucine zipper Kinase; DMSO: dimethyl sulfoxide; DRG: dorsal root ganglion; FOS: Fos proto-oncogene, AP-1 transcription factor subunit; GABA: gamma-aminobutyric acid; GFP: green fluorescent protein; HDA-3: Histone DeAcetylase; IP3: inositol trisphosphate; ITR-1: Inositol Triphosphate Receptor; KLF-2: Kruppel-Like Factor (zinc finger protein) 2; LGG-1: LC3, GABARAP and GATE-16 family; MAK-2: MAP kinase Activated protein Kinase; MAP kinase: mitogen-activated protein kinase; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MKK-4: mitogen activated protein kinase kinase 4; MTOR: mechanistic target of rapamycin kinase; NGM: nematode growth medium; NICD: Notch intracellular domain; NOTCH: notch receptor; PLM: posterior lateral microtubule; PMK-3: P38 Map kinase family; PNS: peripheral nervous system; SCG10: superior cervical ganglion protein 10; SCI: spinal cord injury; UNC-51: UNCoordinated 51; ULK1: unc-51 like autophagy activating kinase 1; wnd: wallenda.</p>
            <hr>

            <h2 class="h4"><a href="#">Acarbose improved survival for Apc<sup>+/Min</sup> mice.</a></h2>
            <p>Dodds SG, Parihar M, Javors M, Nie J, Musi N, Dave Sharp Z, Hasty P</p>
            <p><i>Aging Cell</i>. 2020 Jan 6:e13088. doi: 10.1111/acel.13088. [Epub ahead of print]</p>
            <p><strong>Abstract:</strong></p>
            <p>Acarbose blocks the digestion of complex carbohydrates, and the NIA Intervention Testing Program (ITP) found that it improved survival when fed to mice. Yet, we do not know if lifespan extension was caused by its effect on metabolism with regard to the soma or cancer suppression. Cancer caused death for ~80% of ITP mice. The ITP found rapamycin, an inhibitor to the pro-growth mTORC1 (mechanistic target of rapamycin complex 1) pathway, improved survival and it suppressed tumors in Apc<sup>+/Min</sup> mice providing a plausible rationale to ask if acarbose had a similar effect. Apc<sup>+/Min</sup> is a mouse model prone to intestinal polyposis and a mimic of familial adenomatous polyposis in people. Polyp-associated anemia contributed to their death. To address this knowledge gap, we fed two doses of acarbose to Apc<sup>+/Min</sup> mice. Acarbose improved median survival at both doses. A cross-sectional analysis was performed next. At both doses, ACA fed mice exhibited reduced intestinal crypt depth, weight loss despite increased food consumption and reduced postprandial blood glucose and plasma insulin, indicative of improved insulin sensitivity. Dose-independent and dose-dependent compensatory liver responses were observed for AMPK and mTORC1 activities, respectively. Only mice fed the high dose diet exhibited reductions in tumor number with higher hematocrits. Because low-dose acarbose improved lifespan but failed to reduced tumors, its effects seem to be independent of cancer. These data implicate the importance of improved carbohydrate metabolism on survival.</p>
            <hr>

            <h2 class="h4"><a href="#">TORwards a Victory Over Aging.</a></h2>
            <p> Lamming DW, Salmon AB</p>
            <p><i>J Gerontol A Biol Sci Med Sci</i>. 2020 Jan 1;75(1):1-3. doi: 10.1093/gerona/glz212.</p>
            <hr>

            <h2 class="h4"><a href="#">APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain.</a></h2>
            <p>Lefterov I, Wolfe CM, Fitz NF, Nam KN, Letronne F, Biedrzycki RJ, Kofler J, Han X, Wang J, Schug J, Koldamova R</p>
            <p><i>Alzheimers Res Ther</i>. 2019 Dec 30;11(1):113. doi: 10.1186/s13195-019-0558-0.</p>
            <p><strong>Abstract:</strong></p>
            <p><strong>BACKGROUND:</strong> The application of advanced sequencing technologies and improved mass-spectrometry platforms revealed significant changes in gene expression and lipids in Alzheimer’s disease (AD) brain. The results so far have prompted further research using “multi-omics” approaches. These approaches become particularly relevant, considering the inheritance of APOEε4 allele as a major genetic risk factor of AD, disease protective effect of APOEε2 allele, and a major role of APOE in brain lipid metabolism.</p>

<p><strong>METHODS:</strong> Postmortem brain samples from inferior parietal lobule genotyped as APOEε2/c (APOEε2/carriers), APOEε3/3, and APOEε4/c (APOEε4/carriers), age- and gender-matched, were used to reveal APOE allele-associated changes in transcriptomes and lipidomes. Differential gene expression and co-expression network analyses were applied to identify up- and downregulated Gene Ontology (GO) terms and pathways for correlation to lipidomics data.</p>

<p><strong>RESULTS:</strong> Significantly affected GO terms and pathways were determined based on the comparisons of APOEε2/c datasets to those of APOEε3/3 and APOEε4/c brain samples. The analysis of lists of genes in highly correlated network modules and of those differentially expressed demonstrated significant enrichment in GO terms associated with genes involved in intracellular proteasomal and lysosomal degradation of proteins, protein aggregates and organelles, ER stress, and response to unfolded protein, as well as mitochondrial function, electron transport, and ATP synthesis. Small nucleolar RNA coding units important for posttranscriptional modification of mRNA and therefore translation and protein synthesis were upregulated in APOEε2/c brain samples compared to both APOEε3/3 and APOEε4/c. The analysis of lipidomics datasets revealed significant changes in ten major lipid classes (exclusively a decrease in APOEε4/c samples), most notably non-bilayer-forming phosphatidylethanolamine and phosphatidic acid, as well as mitochondrial membrane-forming lipids.</p>

<p><strong>CONCLUSIONS:</strong> The results of this study, despite the advanced stage of AD, point to the significant differences in postmortem brain transcriptomes and lipidomes, suggesting APOE allele associated differences in pathogenic mechanisms. Correlations within and between lipidomes and transcriptomes indicate coordinated effects of changes in the proteasomal system and autophagy-canonical and selective, facilitating intracellular degradation, protein entry into ER, response to ER stress, nucleolar modifications of mRNA, and likely myelination in APOEε2/c brains. Additional research and a better knowledge of the molecular mechanisms of proteostasis in the early stages of AD are required to develop more effective diagnostic approaches and eventually efficient therapeutic strategies.</p>
            <hr>

            <h2 class="h4"><a href="#">Nexrutine and exercise similarly prevent high grade prostate tumors in transgenic mouse model.</a></h2>
            <p>Patel DI, Abuchowski K, Bedolla R, Rivas P, Musi N, Reddick R, Kumar AP</p>
            <p><i>PLoS One.</i> 2019 Dec 19;14(12):e0226187. doi: 10.1371/journal.pone.0226187. eCollection 2019.</p>
            <p><strong>Abstract:</strong></p>
            <p>The purpose of this investigation was to compare the antitumorigenic effects of the natural product Nexrutine to voluntary wheel running (VWR) in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Forty-five, 10-week old TRAMP mice were randomized to either receive free access to the running wheel, Nexrutine pelleted into chow at 600 mg/kg or no treatment control. Mice were serially sacrificed at weeks 4, 8,12 and 20 weeks. Palpable tumors, body weight, food consumption and running wheel activity were monitored weekly. At necropsy, tumors and serum were harvested and stored for analysis. Serum was used to quantify circulating cytokines in 4 and 20 week time points. Nexrutine supplementation led to a 66% protection against high grade tumors. Exercise resulted in a 60% protection against high grade tumors. Both interventions reduced concentrations of IL-1α. Exercise also significantly lowered concentrations of eotaxin, IL-5, IL-12(p40) and VEGF. While there were no significant differences at baseline, exercise mice had significantly lower IL-5 and VEGF compared to control at the 20 week time point. Nexrutine also significantly reduced circulating IL-9 concentrations. No significant differences were observed when compared to the control group. Immunohistochemistry of tumor sections showed significantly lower expression of pAkt in Nexrutine fed mice with no visible differences for NFκB. In conclusion, both Nexrutine and exercise suppressed tumor growth. Though similar outcomes were seen in this comparative effectiveness study, the mechanisms by which exercise and Nexrutine exert this benefit may focus on different pathways.</p>
            <hr>

            <nav aria-label="Pagination">
                <ul class="pagination">
                    <li class="pagination-previous"><a href="#" aria-label="Previous page"> <span
                                class="show-for-sr"> Previous page</span></a></li>
                    <li><a href="#" aria-label="Page 1">1</a></li>
                    <li class="current"><span class="show-for-sr">You're on page</span> 2</li>
                    <li><a href="#" aria-label="Page 3">3</a></li>
                    <li class="ellipsis" aria-hidden="true"></li>
                    <li><a href="#" aria-label="Page 10">10</a></li>
                    <li><a href="#" aria-label="Page 11">11</a></li>
                    <li><a href="#" aria-label="Page 12">12</a></li>
                    <li class="pagination-next"><a href="#" aria-label="Next page"> <span class="show-for-sr">Next
                                page</span></a></li>
                </ul>
            </nav>
            <p id="stop">
        </main>

        <aside class="cell small-12 medium-5 large-4 small-order-1 medium-order-2" role="complementary" aria-labelledby="filters" data-sticky-container>
            <div class="sticky" data-sticky data-top-anchor="start:top" data-btm-anchor="stop:bottom">
                <div class="callout">
                    <h3 id="filters">Filter List By</h3>
                    <form>
                        <fieldset>
                            <label>Keyword
                                <input type="text">
                            </label>
                        </fieldset>

                        <fieldset>
                            <label>Publication Author
                                <select>
                                <option selected="selected" value="0"></option>
                                    <option value="adam-b-salmon">Adam B. Salmon, PhD</option>
<option value="balakuntalam-kasinath">Balakuntalam Kasinath, MD</option>
<option value="bess-frost">Bess Frost, PhD</option>
<option value="elizabeth-fernandez">Elizabeth Fernandez, PhD</option>
<option value="james-f-nelson">James F. Nelson, PhD</option>
<option value="jp-palavicini">Juan Pablo Palavicini, PhD</option>
<option value="karl-a-rodriguez">Karl A. Rodriguez, PhD</option>
<option value="lisa-kilpela">Lisa Kilpela, PhD</option>
<option value="lizhen-chen">Lizhen Chen, PhD</option>
<option value="masahiro-morita">Masahiro Morita, PhD</option>
<option value="mengwei-zang">Mengwei Zang, MD, PhD</option>
<option value="nicolas-musi">Nicolas Musi, MD</option>
<option value="paul-hasty">Paul Hasty, DVM</option>
<option value="peter-j-hornsby">Peter J. Hornsby, PhD</option>
<option value="randy-strong">Randy Strong, PhD</option>
<option value="sara-e-espinoza">Sara E. Espinoza, MD, MSc</option>
<option value="stacy-a-hussong">Stacy A. Hussong, PhD</option>
<option value="veronica-galvan">Veronica Galvan, PhD</option>
<option value="xianlin-han">Xianlin Han, PhD</option>
<option value="yuguang-shi">Yuguang Shi, PhD</option>
<option value="yuji-ikeno">Yuji Ikeno, MD, PhD</option>
<option value="z-dave-sharp">Z. Dave Sharp, PhD</option>
                                </select>
                            </label>
                        </fieldset>
                        <fieldset>
                            <label>Topics
                                <select>
                                <option selected="selected" value="0"></option>
                                    <option value="aging-and-cancer">Aging and Cancer</option>
                                    <option value="aging-related-neurodegeneration">Aging-Related Neurodegeneration</option>
                                    <option value="comparative-biology-and-invertebrate-models-of-aging">Comparative Biology and Invertebrate Models of Aging</option>
                                    <option value="inflammation-and-immunity">Inflammation and Immunity</option>
                                    <option value="metabolism-endocrinology-and-bioenergetics-of-aging">Metabolism, Endocrinology, and Bioenergetics of Aging</option>
                                    <option value="regenerative-medicine-and-stem-cells">Regenerative Medicine and Stem Cells</option>
                                    <option value="translational-and-interventions">Translational and Interventions</option>
                                </select>
                            </label>
                        </fieldset>

                        <fieldset>
                            <label>Publication Years
                                <select>
                                <option selected="selected" value="0"></option>
                                    <option value="2015">2015</option>
                                    <option value="2015">2016</option>
                                    <option value="2015">2017</option>
                                    <option value="2015">2018</option>
                                    <option value="2015">2019</option>
                                    <option value="2015">2020</option>
                                    <option value="2015">2021</option>
                                </select>
                            </label>
                        </fieldset>
                        <div class="button-group">
    <p><a href="#" class="button">Submit</a></p>
    <p><a href="#" class="button ghost">Reset</a></p>
</div>
                    </form>
                </div>
            </div>
        </aside>
    </div>
</section>
<footer class="flatten">
    <div class="shield">
        <section class="grid-container">
            <div class="grid-x grid-margin-x align-center-middle">
                <div class="cell large-12">
                    <h2>UT Health San Antonio</h2>
                    <h3>San Antonio Claude D. Pepper Older Americans Independence Center</h3>
                </div>
                <div class="cell large-3 medium-4 small-10">
                    <div class="contact">
                        <a href="#" class="fa-stack">
                            <i class="fas fa-circle fa-stack-2x"></i>
                            <i class="fas fa-phone fa-stack-1x fa-inverse"></i>
                        </a>
                        <a href="#">210-562-6140</a> 
                    </div>
                    <div class="contact">
                        <a href="https://uthscsa.edu/university/campus-maps" class="fa-stack">
                            <i class="fas fa-circle fa-stack-2x"></i>
                            <i class="fas fa-map-marker-alt fa-stack-1x fa-inverse"></i>
                        </a> 
                    
                        <address>
                            7703 Floyd Curl Drive, MC 7755<br>
                            San Antonio, TX 78229<br>
                            <a href="https://uthscsa.edu/university/campus-maps" class="arrow">Map and directions</a>
                        </address>
                    </div>

                    <div class="contact">
                        <a href="#" class="fa-stack">
                        <i class="fas fa-circle fa-stack-2x"></i>
                        <i class="fas fa-envelope fa-stack-1x fa-inverse"></i>
                        </a>
                        <a href="#">BarshopInstitute@uthscsa.edu</a> 
                    </div>
                    
                    
                </div>
                <div class="cell large-3 medium-4 small-10">
                    <ul>
                        <li><a href="https://wp.uthscsa.edu/careers/" class="arrow">Job opportunities</a></li>
                        <li><a href="#" class="arrow">Contact Us</a></li>
                        <li><a href="https://makelivesbetter.uthscsa.edu/home" class="arrow">Make a donation</a></li>
                    </ul>

                    <div class="social">
                        <ul>
                            <li><a href="https://www.facebook.com/Barshop.Institute"><i class="fab fa-facebook-square fa-2x"></i></a></li>
                            <li><a href="https://twitter.com/UTHealthBarshop"><i class="fab fa-twitter-square fa-2x"></i></a></li>
                            <li><a href="https://www.youtube.com/@UTHSCSABarshopInstitute"><i class="fab fa-youtube-square fa-2x"></i></a></li>
                        </ul>
                    </div>
                </div>
                <div class="cell large-5 medium-4 small-10">
                    <p class="large-text">We make lives better ®</p>
                    <p>The University of Texas Health Science Center at San Antonio, also called <a href="#">UT Health San Antonio</a>, is a leading academic health center with a mission to make lives better through excellence in <a href="#">advanced academics</a>, <a href="#">life-saving research</a> and comprehensive clinical care including <a href="#">health</a>, <a href="#">dental</a> and <a href="#">cancer services</a>.</p>
                </div>
                <div class="cell large-1 medium-0 small-0"></div>
            </div>    
        </section>
    </div>
    <section class="bleed">
        <div class="grid-container">
            <div class="grid-x">
                <div class="cell">
                    <p><strong><a href="#">Web Privacy</a></strong> | Links from websites affiliated with UT Health's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.</p>
                </div>
            </div>
        </div>
    </section>
</footer><script type="text/json" id="pl-pattern-data-footer" class="pl-js-pattern-data">
  {"cssEnabled":false,"patternLineageExists":true,"patternLineages":[{"lineagePattern":"components-header-pepper","lineagePath":"../../patterns/components-header-prototypes-header-pepper/components-header-prototypes-header-pepper.rendered.html"},{"lineagePattern":"components-navbar-pepper","lineagePath":"../../patterns/components-navigation-prototypes-navbar-pepper/components-navigation-prototypes-navbar-pepper.rendered.html"},{"lineagePattern":"components-pepper-footer","lineagePath":"../../patterns/components-footer-prototypes-pepper-footer/components-footer-prototypes-pepper-footer.rendered.html"}],"lineage":[{"lineagePattern":"components-header-pepper","lineagePath":"../../patterns/components-header-prototypes-header-pepper/components-header-prototypes-header-pepper.rendered.html"},{"lineagePattern":"components-navbar-pepper","lineagePath":"../../patterns/components-navigation-prototypes-navbar-pepper/components-navigation-prototypes-navbar-pepper.rendered.html"},{"lineagePattern":"components-pepper-footer","lineagePath":"../../patterns/components-footer-prototypes-pepper-footer/components-footer-prototypes-pepper-footer.rendered.html"}],"patternLineageRExists":false,"patternLineagesR":[],"lineageR":[],"patternLineageEExists":true,"patternDesc":"<ul>\n<li>\n<p>The Header uses the <code>.logo .pipe</code> along with 2 icon links and <code>quicklinks</code></p>\n</li>\n<li>\n<p>The <code>.hero</code> banner has a <code>.callout</code> with an optional Contact <code>.button</code></p>\n</li>\n</ul>\n","patternBreadcrumb":{"patternGroup":"prototypes","patternSubgroup":"Pepper Center"},"patternExtension":"twig","patternName":"Publications","patternPartial":"prototypes-pepper-pub","patternState":"","patternEngineName":"twig-php","extraOutput":{"order":6}}
</script>

<script>
  window.patternData = {"cssEnabled":false,"patternLineageExists":true,"patternLineages":[{"lineagePattern":"components-header-pepper","lineagePath":"../../patterns/components-header-prototypes-header-pepper/components-header-prototypes-header-pepper.rendered.html"},{"lineagePattern":"components-navbar-pepper","lineagePath":"../../patterns/components-navigation-prototypes-navbar-pepper/components-navigation-prototypes-navbar-pepper.rendered.html"},{"lineagePattern":"components-pepper-footer","lineagePath":"../../patterns/components-footer-prototypes-pepper-footer/components-footer-prototypes-pepper-footer.rendered.html"}],"lineage":[{"lineagePattern":"components-header-pepper","lineagePath":"../../patterns/components-header-prototypes-header-pepper/components-header-prototypes-header-pepper.rendered.html"},{"lineagePattern":"components-navbar-pepper","lineagePath":"../../patterns/components-navigation-prototypes-navbar-pepper/components-navigation-prototypes-navbar-pepper.rendered.html"},{"lineagePattern":"components-pepper-footer","lineagePath":"../../patterns/components-footer-prototypes-pepper-footer/components-footer-prototypes-pepper-footer.rendered.html"}],"patternLineageRExists":false,"patternLineagesR":[],"lineageR":[],"patternLineageEExists":true,"patternDesc":"<ul>\n<li>\n<p>The Header uses the <code>.logo .pipe</code> along with 2 icon links and <code>quicklinks</code></p>\n</li>\n<li>\n<p>The <code>.hero</code> banner has a <code>.callout</code> with an optional Contact <code>.button</code></p>\n</li>\n</ul>\n","patternBreadcrumb":{"patternGroup":"prototypes","patternSubgroup":"Pepper Center"},"patternExtension":"twig","patternName":"Publications","patternPartial":"prototypes-pepper-pub","patternState":"","patternEngineName":"twig-php","extraOutput":{"order":6}};
</script>

<script>
  /*!
   * scriptLoader - v0.1
   *
   * Copyright (c) 2014 Dave Olsen, http://dmolsen.com
   * Licensed under the MIT license
   *
   */

  var scriptLoader = {

    run: function(js,cb,target) {
      var s  = document.getElementById(target+'-'+cb);
      for (var i = 0; i < js.length; i++) {
        var src = (typeof js[i] != 'string') ? js[i].src : js[i];
        var c   = document.createElement('script');
        c.src   = '../../'+src+'?'+cb;
        if (typeof js[i] != 'string') {
          if (js[i].dep !== undefined) {
            c.onload = function(dep,cb,target) {
              return function() {
                scriptLoader.run(dep,cb,target);
              }
            }(js[i].dep,cb,target);
          }
        }
        s.parentNode.insertBefore(c,s);
      }
    }

  }
</script>

<script id="pl-js-polyfill-insert-1729607112045">
  (function() {
    if (self != top) {
      var cb = '1729607112045';
      var js = [];
      scriptLoader.run(js,cb,'pl-js-polyfill-insert');
    }
  })();
</script>


<script type="module">
  // always load Pattern-specific JS so UI like accordions, etc can continue to work even when viewed as a standalone HTML page
  import('../../styleguide/js/patternlab-pattern.modern.js');
</script>

<script id="pl-js-insert-1729607112045" nomodule>
  /*! loadJS: load a JS file asynchronously. [c]2014 @scottjehl, Filament Group, Inc. (Based on https://goo.gl/REQGQ by Paul Irish). Licensed MIT */
  !function(e){var t=function(t,n){"use strict";var o=e.document.getElementsByTagName("script")[0],r=e.document.createElement("script");return r.src=t,r.async=!0,o.parentNode.insertBefore(r,o),n&&"function"==typeof n&&(r.onload=n),r};"undefined"!=typeof module?module.exports=t:e.loadJS=t}("undefined"!=typeof global?global:this);

  // always load Pattern-specific JS so UI like accordions, etc can continue to work even when viewed as a standalone HTML page
  loadJS('../../styleguide/js/patternlab-pattern.js');
</script>


<script type="text/javascript" src="../../js/vendor/jQuery/jquery.min.js"></script>
<script type="text/javascript" src="../../js/vendor/foundation/foundation.min.js"></script>
<script type="text/javascript" src="../../js/vendor/motion-ui/motion-ui.min.js"></script>
<script type="text/javascript" src="../../js/shield.min.js"></script>
<script type="text/javascript" src="../../js/vendor/what-input/what-input.min.js"></script>
</body>

</html>